Couper JJ, Haller MJ, Greenbaum CJ, Ziegler AG, Wherrett DK, Knip M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr Diabetes 2018;19 Suppl 27:20–7. https://www.ncbi.nlm.nih.gov/pubmed/30051639
Craig ME, Twigg SM, Donaghue K, Cheung NW, Cameron FJ. National evidence-based clinical care guidelines for type 1 diabetes for children, adolescents and adults. Canberra: Australian Department of Health and Ageing; 2011. www.diabetessociety.com.au/position-statements.asp
Diabetes Canada Clinical Practice Guidelines Expert Committee, Wherrett DK, Ho J, Huot C, Legault L, Nakhla M, et al.Type 1 diabetes in children and adolescents. Can J Diabetes 2018;42 Suppl 1:S234–S46. https://www.ncbi.nlm.nih.gov/pubmed/29650103
Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 2018;19 Suppl 27:7–19. https://www.ncbi.nlm.nih.gov/pubmed/30226024
O'Connell SM, Cooper MN, Bulsara MK, Davis EA, Jones TW. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009. Diabetes Care 2011;34(11):2379–80. https://www.ncbi.nlm.nih.gov/pubmed/21926291
Swift PG, Skinner TC, de Beaufort CE, Cameron FJ, Aman J, Aanstoot HJ, et al. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr Diabetes 2010;11(4):271–8. https://www.ncbi.nlm.nih.gov/pubmed/19895567
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977–86. https://www.ncbi.nlm.nih.gov/pubmed/8366922
